South Denver Cardiology Associates, PC

Littleton, Colorado 80120-5654

5 studies enrolling now · 57 studies all time

What they study most

Acute Coronary Syndrome, Acute Interstitial Pneumonitis, Acute Myocardial Infarction, Adverse Effect of MRI on an Implanted Pacemaker, Adverse Effect of MRI on an Implanted Pacemaker Lead, Angina Pectoris, Arthritis, Rheumatoid, Atrial Arrhythmia, Atrial Fibrillation, Atrial Fibrillation (AF), Atrial Flutter, Bleeding

Studies at this site

• FORWARD CAD IDE Study — Recruiting now
• AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions — Recruiting now
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System — Recruiting now
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
• VOLT-AF IDE Clinical Study — Completed
• Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) — Stopped early
• Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: — Completed
• Aveir DR i2i Study — Completed
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT — Completed
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Stopped early
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 — Stopped early
• Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — Stopped early
• TactiFlex Paroxysmal Atrial Fibrillation IDE Trial — Completed
• TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation — Completed
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure — Completed
• Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Lead Registry for Optim Leads — Completed
• St. Jude Medical Product Longevity and Performance (SCORE) Registry — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead — Completed
• EVOLVE Short DAPT Study — Completed
• Beraprost-314d Added-on to Tyvaso® (BEAT) — Completed
• SJM MRI Diagnostic Imaging Registry (IDE) — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator — Completed
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed
• Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant — Completed
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
• Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program — Completed